To demonstrate whether the activation of Smad2/3 and p38 is specific to TGF-β signaling triggered by tumor exosomes, we blocked TGF-β signaling pathway with TGF-β R1inhibitor and detected the levels of phosphorylated Smad2/3 and p38. Here, TGFB1 is linked to neoplasm.